Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.43 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20047167 | 0.91 | L3MBTL1 (0.50) | KMT2AMEN1AKR1C3L3MBTL1OPRK1 | |
| SCHEMBL20047023 | 0.85 | AKR1C3 (0.49) | KMT2AMEN1AKR1C3AKR1C1L3MBTL1 | |
| SCHEMBL20047031 | 0.85 | AKR1C3 (0.48) | KMT2AMEN1AKR1C3AKR1C1L3MBTL1 | |
| SCHEMBL20047030 | 0.84 | KMT2A (0.51) | KMT2AMEN1AKR1C3AKR1C1L3MBTL1 | |
| SCHEMBL20047029 | 0.83 | CYP11B1 (0.50) | CYP11B1CYP11B2 | |
| SCHEMBL20047024 | 0.83 | CHRM5 (0.41) | KMT2AMEN1AKR1C3AKR1C1L3MBTL1 | |
| SCHEMBL20047027 | 0.82 | PKM (0.51) | KMT2AMEN1AKR1C3AKR1C1L3MBTL1 | |
| SCHEMBL20047020 | 0.82 | MEN1 (0.40) | KMT2AMEN1AKR1C3AKR1C1L3MBTL1 | |
| SCHEMBL20047019 | 0.81 | MEN1 (0.40) | KMT2AMEN1AKR1C3AKR1C1L3MBTL1 | |
| SCHEMBL22484651 | 0.81 | L3MBTL1 (0.53) | KMT2AMEN1AKR1C3L3MBTL1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017223514-A9 | LXR INVERSE AGONISTS FOR TREATMENT OF CANCER | SAINT LOUIS UNIVERSITY (US) | 2018-04-12 | — | — | WO | disclosed |